| P50 | author | Sathyamangalam Swaminathan | Q55188615 |
| | Navin Khanna | Q104801234 |
| P2093 | author name string | Poornima Tyagi | |
| | Upasana Arora | |
| P2860 | cites work | Measurement of protein using bicinchoninic acid | Q26778491 |
| | M2e-based universal influenza A vaccine | Q30227479 |
| | Phase I trial of an alhydrogel adjuvanted hepatitis B core virus-like particle containing epitopes of Plasmodium falciparum circumsporozoite protein | Q33318466 |
| | Dengue vaccines: state of the art. | Q34109652 |
| | HBV core particles as a carrier for B cell/T cell epitopes | Q34339579 |
| | Heterologous protein production using the Pichia pastoris expression system. | Q36036987 |
| | Theileria annulata sporozoite antigen fused to hepatitis B core antigen used in a vaccination trial | Q36792907 |
| | Virus-like particles: flexible platforms for vaccine development | Q36837144 |
| | Native display of complete foreign protein domains on the surface of hepatitis B virus capsids. | Q37163704 |
| | Domain III of the envelope protein as a dengue vaccine target | Q37682895 |
| | An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes. | Q39941197 |
| | Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2. | Q40280642 |
| | Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies. | Q40364336 |
| | Contribution of disulfide bridging to epitope expression of the dengue type 2 virus envelope glycoprotein | Q40540353 |
| | Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection. | Q45417527 |
| | A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula | Q45519794 |
| | An amino-terminal segment of hantavirus nucleocapsid protein presented on hepatitis B virus core particles induces a strong and highly cross-reactive antibody response in mice. | Q45635121 |
| | Plant-produced hepatitis B core protein chimera carrying anthrax protective antigen domain-4. | Q46426426 |
| | A novel virus-like particle based on hepatitis B core antigen and substrate-binding domain of bacterial molecular chaperone DnaK. | Q50582328 |
| | HBV core particles allow the insertion and surface exposure of the entire potentially protective region of Puumala hantavirus nucleocapsid protein. | Q52979262 |
| | Highly efficient production of phosphorylated hepatitis B core particles in yeast Pichia pastoris | Q58005152 |
| | Efficacy of Human Papillomavirus-16 Vaccine to Prevent Cervical Intraepithelial Neoplasia | Q60441062 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Dengue virus | Q476209 |
| P304 | page(s) | 873-878 | |
| P577 | publication date | 2012-12-20 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice | |
| P478 | volume | 31 | |